Award notice Supplies

adquisición del fármaco Alyftrek® 125mg/50mg/10mg comp rec con película, 56 comprimidos y Alyftrek® 50mg/20mg/4mg comp rec con película, 84 comprimidos (Deutivacaftor/Tezacaftor/Vanzacaftor)

Notice published in Spanish. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: Hospital Universitario Ramón y Cajal
MADRID
Place of performance: Madrid
Estimated value: €2,768,198 excl. VAT
Amount awarded: €2,768,198 excl. VAT
Bids received: 1
Procedure: Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication: 18 September 2026
Notice language: Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

adquisición del fármaco Alyftrek® 125mg/50mg/10mg comp rec con película, 56 comprimidos y Alyftrek® 50mg/20mg/4mg comp rec con película, 84 comprimidos (Deutivacaftor/Tezacaftor/Vanzacaftor), con destino al Servicio de Farmacia del Hospital Universitario Ramón y Cajal

Awarded to

VERTEX PHARMACEUTICALS SPAIN, S.L.

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33673000

Similar contracts already awarded

Contract	Winner	Amount
Suministro de adquisición del kAFTRIO, para el Servicio de Farmacia del Hospital Universitario Ramón y Cajal. Hospital Universitario Ramón y Cajal · 16 September 2026	VERTEX PHARMACEUTICALS SPAIN, S.L.	€2,356,603

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 644849-2026.